Patents by Inventor Masaru Taniguchi

Masaru Taniguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diabetes mellitus using variable .alpha. domain of T-cell receptor
    Patent number: 5648332
    Abstract: A soluble T-cell receptor .alpha.-chain produced by suppressor T-cell. The said soluble T-cell receptor .alpha.-chain is useful as a prophylactic and therapeutic agent for autoimmune diseases generated to a wide variety of autoantigens irrespective of specificity to the said suppressor T-cell.
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: July 15, 1997
    Assignee: Hoechst Japan Limited
    Inventors: Hiroshi Watanabe, Nobuyuki Yamagata, Masaru Taniguchi
  • Human monoclonal antibody to lung carcinoma and hybridoma producing the same
    Patent number: 4800155
    Abstract: A human-mouse hybridoma producing a human monoclonal antibody specific for human lung squamous and adenocarcinomas. The human monoclonal antibody can be utilized as a diagnostic agent in serological diagnosis, in the radioimmaging of lung tumors or as a therapeutic agent.
    Type: Grant
    Filed: February 9, 1987
    Date of Patent: January 24, 1989
    Assignees: Yoshitomi Pharmaceutical Industries, Ltd., Masaru Taniguchi
    Inventors: Masaru Taniguchi, Hiroaki Saito, Yutaka Yamaguchi, Fumio Hiraoka, Ikuro Nakamura